Sleep-disordered Breathing in Infants With Myelomeningocele
- Conditions
- MyelomeningoceleSleep-disordered Breathing
- Interventions
- Diagnostic Test: neonatal polysomnographyDiagnostic Test: 2-year Bayley ExamDiagnostic Test: 2-year polysomnography
- Registration Number
- NCT04251806
- Lead Sponsor
- University of Michigan
- Brief Summary
This study aims to determine whether the risk for sleep-disordered breathing in infants with myelomeningocele (a severe form of spina bifida) differs among those who underwent fetal vs. postnatal surgery, and to examine the link between sleep-disordered breathing and neurodevelopment.
- Detailed Description
Myelomeningocele (MMC), the most severe form of spina bifida, is characterized by exposure of the spinal cord through a spinal defect. Sleep-disordered breathing (SDB) is common in children with MMC and is a risk factor for sudden death. Abnormal sleep physiology is likely multifactorial, related to MMC level, brainstem dysfunction, musculoskeletal factors, and pulmonary abnormalities. In infants, SDB may be treatable with oxygen, caffeine, or positive airway pressure. Yet, SDB screening is not routine, even in centers with specialized MMC programs.
Evaluation of sleep in neonates who require intensive care is an emerging opportunity with potential for major impact on health and quality of life for affected children. As SDB and abnormal sleep are potentially treatable, early assessment and intervention could become an integral part of a multidisciplinary treatment strategy to optimize long-term medical and neurodevelopmental outcomes.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 173
neonates with myelomeningocele who are cared for at a study center NICU are eligible to participate after myelomeningocele repair.
- born at <30 weeks gestation
- congenital anomalies that would predispose to sleep-disordered breathing (e.g. micrognathia)
- confirmed or suspected genetic syndromes that alter developmental outcomes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Prenatal Repair 2-year Bayley Exam This group received prenatal myelomeningocele repair. Prenatal Repair 2-year polysomnography This group received prenatal myelomeningocele repair. Postnatal Repair 2-year Bayley Exam This group received postnatal myelomeningocele repair. Prenatal Repair neonatal polysomnography This group received prenatal myelomeningocele repair. Postnatal Repair neonatal polysomnography This group received postnatal myelomeningocele repair. Postnatal Repair 2-year polysomnography This group received postnatal myelomeningocele repair.
- Primary Outcome Measures
Name Time Method Evaluation of neonatal sleep-disordered breathing (SDB) in infants who had fetal versus postnatal myelomeningocele repair. 35-42 weeks postmenstrual age Neonatal sleep studies will be used to capture neonatal Apnea-Hypopnea Index (AHI), the most widely accepted summary measure of sleep-disordered breathing severity for newborns who had fetal (prenatal) versus postnatal myelomeningocele repair.
- Secondary Outcome Measures
Name Time Method Association between neonatal sleep-disordered breathing and neurodevelopmental outcomes at 2 years of age for infants with myelomeningocele. 22-26 months corrected age Bayley-IV developmental exams will be performed on all subjects around 2-years of age. The Bayley-IV will determine if the subject's level of thinking, language, and motor skills are similar to the level of most children their age. Our assessment will be based off the Cognitive Subscale Score. It has a range from 40-160 with a mean score of 100 and standard deviation of 15. The scores will analyzed with regression models and general linear models to see if there is an association between Neonatal AHI for infants with myelomeningocele, fetal vs. postnatal myelomeningocele repairs, and neurodevelopmental outcomes.
Persistence of sleep-disordered breathing at 2-years of age 22-26 months corrected age Sleep studies will be performed at 2-years of age to capture AHI and compare to neonatal AHI for neonates who had fetal versus postnatal myelomeningocele repair.
Trial Locations
- Locations (9)
Children's Hospital Colorado
๐บ๐ธAurora, Colorado, United States
Mott Children's Hospital
๐บ๐ธAnn Arbor, Michigan, United States
Washington University
๐บ๐ธSaint Louis, Missouri, United States
University of Alabama at Birmingham
๐บ๐ธBirmingham, Alabama, United States
Children's Hospital of Philadelphia
๐บ๐ธPhiladelphia, Pennsylvania, United States
University of Texas-Houston
๐บ๐ธHouston, Texas, United States
Children's Minnesota
๐บ๐ธMinneapolis, Minnesota, United States
Cincinnati Children's Hospital Medical Center
๐บ๐ธCincinnati, Ohio, United States
Mayo Clinic
๐บ๐ธRochester, Minnesota, United States